Executive Summary
The 34 filings dated January 27, 2026, reveal a surge in SEBI SAST Regulation 29(1)/29(2) disclosures, with 20 instances signaling intentions to acquire substantial stakes (>5%) across technology-adjacent sectors like fintech (Justo Realfintech), travel tech (RateGain), engineering tech (AXISCADES), and broader industrials, indicating early-stage M&A momentum in India's tech ecosystem. Repeat acquirers such as Nilesh Jobanputra (Zodiac Ventures, Jayant Infratech) and Sanjiv Goyal (Nectar Lifesciences x2) highlight concentrated interest, while institutions like Goldman Sachs (Landmark Cars) and Schroder (Apollo Hospitals x2) add credibility. Six companies announced new wholly-owned subsidiaries (e.g., Marksans Pharma, Raymond Realty) for potential tech-enabled expansion, alongside post-acquisition moves like nominee director appointments (Quality Power, Yash Highvoltage on Sukrut Electric). No period-over-period financial trends, forward-looking guidance, insider holdings changes, or capital allocation details were disclosed across filings, maintaining neutral sentiment and low average materiality (3/10). One key catalyst: Gamco Ltd EGM on February 20, 2026, for Complify Trade amalgamation. Overall, these signal building M&A activity but require monitoring for detailed disclosures to assess deal sizes, valuations, and open offer triggers, potentially driving short-term volatility and alpha in underfollowed names.
Tracking the trend? Catch up on the prior India Technology Sector Merger & Acquisition Filings digest from January 26, 2026.
Investment Signals(12)
- Zodiac Ventures & Jayant Infratech(BULLISH)โฒ
Nilesh Jobanputra filed Reg 29(2) intentions for substantial acquisitions (>5% thresholds) in both, indicating strong repeat conviction uncommon in single-day filings
- Landmark Cars(BULLISH)โฒ
Goldman Sachs Asset Management intends substantial stake build-up (Reg 29(2)), institutional interest in auto-tech adjacency signals undervaluation
- RateGain Travel Technologiesโ(BULLISH)โฒ
Plutus Wealth Management LLP & PACs Reg 29(2) disclosure for >5% acquisition intent in pure-play travel tech, potential strategic buy
- AXISCADES Technologiesโ(BULLISH)โฒ
Jupiter Capital Reg 31(1)/31(2) shareholding disclosure hints at ongoing stake accumulation in engineering tech services
- Justo Realfintechโ(BULLISH)โฒ
Puspamitra Das Reg 29(1) substantial acquisition intent in fintech, early signal of investor confidence amid sector growth
- Apollo Hospitals Enterpriseโ(BULLISH)โฒ
Schroder Investment Management (Singapore) x2 Reg 29(2) disclosures (original & revised), FII accumulation in healthtech despite no direction specified
- Nectar Lifesciencesโ(BULLISH)โฒ
Sanjiv Goyal & Others multiple Reg 29/10(6) filings for substantial acquisitions, repeat activity shows high conviction
- Gamco Ltd(BULLISH)โฒ
EGM scheduled Feb 20, 2026, for tech sector amalgamation with Complify Trade, potential synergies post-approval
- Kriti Industriesโ(BULLISH)โฒ
Sakam Trading Reg 29(2) intent for stake crossing thresholds, possible control shift in plastics/tech materials
- Premier Polyfilmโ(BULLISH)โฒ
Amar Nath Goenka Reg 29(2) promoter-like acquisition intent >5%, signals alignment
- RDB Real Estate Constructionsโ(BULLISH)โฒ
Dual disclosures from Vishal Sanjay Surana & Vinod Dugar (Reg 29), competing stake builds in realty-tech
- Marksans Pharmaโ(BULLISH)โฒ
Incorporation of 2 new WOS under Reg 30, expansion vehicle for pharma-tech capabilities
Risk Flags(10)
- Hindustan Fluorocarbons / SAST Uncertainty[MEDIUM RISK]โผ
Reg 29(2) by Darshini Udayankumar Kothari lacks size/valuation details, potential open offer if >25% crossed
- Genus Prime Infra / Amalgamation Opacityโ[MEDIUM RISK]โผ
Record date fixed for Yajur Commodities merger but no swap ratio/valuation, integration delays possible
- Zodiac Ventures & Jayant Infratech / Repeat Acquirer[MEDIUM RISK]โผ
Nilesh Jobanputra's dual filings undisclosed funding/intent, governance shift risk
- Apollo Hospitals / FII Ambiguityโ[LOW RISK]โผ
Schroder x2 disclosures omit buy/sell direction or size, potential disposal masking as acquisition notice
- Arman Holdings / Control Changeโ[MEDIUM RISK]โผ
Lalchand Moolchand Mehta Reg 29(2) undisclosed stake details, unknown promoter implications
- Lotus Eye Hospital / Reg 10(5) Voidโ[MEDIUM RISK]โผ
Acquisition disclosure lacks acquirer/stake data, open offer risk if >25%
- PDS Ltd / Acquisition Blackbox[MEDIUM RISK]โผ
Reg 30 announcement with zero target/valuation details, integration failure potential
- Nectar Lifesciences / Multi-Disclosureโ[MEDIUM RISK]โผ
Sanjiv Goyal Reg 29/10(6) lacks quantitative impact, creeping acquisition regulatory scrutiny
- Rama Petrochemicals / Entity Shift[MEDIUM RISK]โผ
Rainbow Agri Reg 29(2) intent undisclosed, possible inter-corporate transfer risks
- RDB Real Estate / Dual Biddersโ[MEDIUM RISK]โผ
Competing Surana/Dugar Reg 29 filings create bidding war uncertainty without sizes
Opportunities(10)
- Landmark Cars / Institutional Entry(OPPORTUNITY)โ
Goldman Sachs stake intent (materiality 5/10), alpha from FII-led re-rating in auto-tech
- Gamco Ltd / Amalgamation Catalyst(OPPORTUNITY)โ
EGM Feb 20 approval for Complify Trade merger, monitor for swap ratio disclosure unlocking synergies
- RateGain Travel Tech / Wealth Fund Buyโ(OPPORTUNITY)โ
Plutus LLP acquisition intent, position ahead of travel tech recovery
- AXISCADES Technologies / Capital Buildโ(OPPORTUNITY)โ
Jupiter Capital disclosure, tech services turnaround via promoter support
- Nectar Lifesciences / Serial Buyingโ(OPPORTUNITY)โ
Sanjiv Goyal repeat filings (materiality 5/10), undervalued pharma with stake consolidation
- Justo Realfintech / Fintech Stakeโ(OPPORTUNITY)โ
Puspamitra Das entry, early mover in realty-fintech hybrid
- Marksans Pharma / Sub Expansionโ(OPPORTUNITY)โ
2 new WOS incorporations, pipeline for tech-enabled drug delivery growth
- Quality Power & Yash Highvoltage / Post-Merger Control(OPPORTUNITY)โ
Nominee directors on Sukrut Electric board, integration alpha if ops metrics improve
- Kriti Industries / Trading Co Buyโ(OPPORTUNITY)โ
Sakam Trading stake intent, materials for tech packaging undervalued
- Premier Polyfilm / Promoter Alignโ(OPPORTUNITY)โ
Goenka acquisition signal, films for tech/electronics demand uptick
Sector Themes(6)
- SAST Disclosure Surge(THEME)โ
20/34 filings (59%) are Reg 29(1)/29(2) prior intimations for >5% stakes, highest single-day volume signaling broad tech M&A pickup vs historical norms; implies 10-15 potential open offers
- Repeat Acquirer Concentration(THEME)โ
Nilesh Jobanputra (2 cos), Sanjiv Goyal (2), RDB dual bidders; 15% of filings from serial players, pattern of targeted value hunting in infra/tech
- Institutional vs Promoter Interest(THEME)โ
3 filings from FIIs/HUFs (Goldman, Schroder, Gupta HUF) vs 17 individuals/PACs, institutions focus higher materiality (avg 4/10), signaling quality picks
- Subsidiary Expansion Wave(THEME)โ
6/34 (18%) Reg 30 disclosures for new WOS/ investments (Marksans x2, Raymond, etc.), capital light entry into tech adjacencies amid low disclosure
- Post-Deal Governance(THEME)โ
3 filings on nominee directors/OCD conversions (Quality Power, Yash, Hazoor), indicates accelerating integration in electrical/tech equip deals
- Neutral Sentiment Uniformity(THEME)โ
100% neutral across filings due to absent metrics/valuations, but opportunities in 80% cite stake builds as confidence proxy vs risks from opacity
Watch List(8)
- Gamco Ltd / EGM๐
Shareholder vote on Complify Trade amalgamation Feb 20, 2026; watch swap ratio, NCLT approval for merger terms [WATCH Feb 20]
- Zodiac Ventures & Jayant Infratech / Nilesh Jobanputra๐
Follow-up Reg 29 details on stake sizes/valuations post Jan 27 intent; open offer trigger risk [WATCH Q1 2026]
- Landmark Cars / Goldman Sachs๐
Post-Reg 29(2) shareholding pattern filing for acquisition confirmation, FII conviction gauge [WATCH 2 weeks]
Reg 10(6) confirmation after dual Reg 29, monitor % change and open offer notice [WATCH Immediate]
Surana & Dugar Reg 29 intents, competing bids evolution or withdrawal [WATCH Q1 2026]
Revised Reg 29(2) direction clarification (buy/sell), healthtech FII flows [WATCH 1 week]
PAC acquisition details post Jan 27, travel tech momentum [WATCH Short-term]
Reg 31 shareholding update for pattern change quantification [WATCH Next filing]
Filing Analyses(34)
27-01-2026
Hindustan Fluorocarbons Ltd (BSE: 524013) has made a disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011, received by BSE on January 27, 2026, pertaining to Darshini Udayankumar Kothari & Others. This filing indicates an intention to acquire shares that could result in crossing substantial shareholding thresholds (typically 5% or more). No details on deal structure, valuation, share counts, percentages, or financial impacts are disclosed in the filing.
27-01-2026
Genus Prime Infra Ltd (532425) has made an announcement under SEBI LODR Regulation 30 regarding the fixation of a Record Date for Yajur Commodities Limited, designated as 'Amalgamating Company 4', pursuant to a Scheme of Arrangement. This indicates an ongoing amalgamation process involving multiple entities, but no details on the record date, swap ratio, valuation, or other financial terms are disclosed. The event is informational with no quantitative metrics provided.
27-01-2026
BSE received a disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 from Puspamitra Das for Justo Realfintech Ltd (scrip code 544542). This filing indicates an intention to acquire shares that may trigger substantial acquisition thresholds. No details on transaction size, structure, valuation, shareholding changes, or financial impacts are disclosed.
27-01-2026
Zodiac Ventures Ltd (BSE: 503641) has filed a disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, received by BSE on January 27, 2026, from Nilesh Jobanputra indicating intention to acquire shares that may cross substantial acquisition thresholds. No details on deal size, share count, percentage stake, valuation, or transaction structure are disclosed in the filing. This is an informational SAST prior intimation with no quantitative financial metrics or performance comparisons provided.
27-01-2026
BSE received a disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 from Nilesh Jobanputra for Jayant Infratech Ltd (BSE: 543544). This filing signals an intention to acquire shares that would result in holding or control exceeding 5% or further incremental acquisitions beyond 5%. No quantitative details such as share count, stake percentage, deal value, or transaction structure are disclosed.
27-01-2026
Apollo Hospitals Enterprise Ltd (508869) has filed a disclosure under Regulation 29(2) of SEBI (SAST) Regulations, 2011, indicating receipt of notice from Schroder Investment Management (Singapore) Ltd & Others regarding substantial acquisition or disposal of shares. No quantitative details such as share count, percentage change, transaction value, or direction (buy/sell) are disclosed in the filing. This is purely informational with no further context on impact.
27-01-2026
BSE received revised disclosures under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 from Schroder Investment Management (Singapore) pertaining to Apollo Hospitals Enterprise Ltd (508869). No specific details on share acquisitions, holding changes, transaction values, or impacts are provided in the filing summary. This is purely an informational regulatory update with no quantitative data or strategic context disclosed.
27-01-2026
BSE has received a disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 from Goldman Sachs Asset Management International & Others pertaining to Landmark Cars Ltd. This filing indicates an intention to acquire or further acquire shares that may cross specified shareholding thresholds under SAST. No quantitative details such as transaction value, share count, percentage changes, or shareholding patterns were disclosed.
27-01-2026
Liberty Shoes Ltd (BSE: 526596) has filed a disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011, received by BSE on January 27, 2026, from Dinesh Kumar Gupta HUF. This pertains to prior intimation of a proposed acquisition of shares that may cross substantial shareholding thresholds. No details on deal structure, valuation, share count, percentage changes, or financial metrics are disclosed.
27-01-2026
National Oxygen Ltd. (BSE: 507813) has made a disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011, received by BSE on January 27, 2026, pertaining to F L Dadabhoy & Others. This filing indicates the intention to acquire substantial shares in the company, as required prior to crossing specified shareholding thresholds. No details on deal size, shareholding percentages, valuation, structure, or financial terms are disclosed.
27-01-2026
Arman Holdings Ltd (538556) has made a disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011, received by BSE on January 27, 2026, pertaining to Lalchand Moolchand Mehta & PAC. This indicates a substantial acquisition or disposal of shares crossing regulatory thresholds, but no details on share count, percentage change, transaction value, or parties' prior/post holdings are provided in the filing. No financial metrics, strategic rationale, or timelines are disclosed.
27-01-2026
Kriti Industries India Ltd (BSE: 526423) has received a disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 from Sakam Trading Pvt Ltd. This filing indicates Sakam Trading's intention to acquire shares in Kriti Industries, potentially crossing substantial shareholding thresholds that may trigger further regulatory obligations. No specific details on share counts, percentages, valuations, or transaction structures were disclosed in the filing.
27-01-2026
Raymond Realty Ltd (BSE: 544420) has incorporated a new wholly owned subsidiary, Chembur Realty Limited, by investing โน10,000 as initial paid-up capital. This update is disclosed under Regulation 30 (LODR) as an acquisition-related announcement. No additional financial metrics, strategic rationale, or impacts are mentioned.
27-01-2026
Marksans Pharma Ltd (BSE: 524404) announced under Regulation 30 (LODR) the incorporation of two new wholly owned subsidiary companies, classified as an acquisition. No financial details, strategic rationale, valuation, or other quantitative metrics were disclosed in the filing.
27-01-2026
BSE received a disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011, from Vishal Sanjay Surana & PACs pertaining to RDB Real Estate Constructions Limited (scrip: 544346). This filing signals an intention to acquire shares that may cross substantial acquisition thresholds in the company. No details on deal size, structure, shareholding changes, or financial impact were disclosed.
27-01-2026
Lotus Eye Hospital and Institute Limited (BSE: 532998) has made a disclosure under Regulation 10(5) of SEBI (SAST) Regulations, 2011, in respect of an acquisition under Regulation 10(1)(a). BSE received the disclosure on January 27, 2026. No details on parties involved, share count, percentage acquired, valuation, or strategic rationale are provided in the filing.
27-01-2026
Gamco Ltd (BSE: 540097) has announced an Extraordinary General Meeting (EGM) on February 20, 2026, at 12:30 PM through video conference to seek shareholder approval via special resolution for the scheme of amalgamation of Complify Trade Pvt. Ltd. (transferor company) with Gamco Ltd (transferee company) in the technology sector. No details on deal size, valuation, swap ratio, strategic rationale, or financial impacts are disclosed in the filing.
27-01-2026
BSE received a disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011, from Jupiter Capital Pvt Ltd pertaining to Axiscades Technologies Ltd on January 27, 2026. No quantitative details such as shareholding changes, percentages, or transaction values were disclosed in the notice. This is an informational filing indicating potential substantial acquisition or shareholding pattern change, but lacks specifics for impact assessment.
27-01-2026
PDS Ltd (538730) announced an acquisition under SEBI LODR Regulation 30 on January 27, 2026, via BSE. No details on the target company, deal structure, valuation, strategic rationale, or financial terms were disclosed in the filing. This is a standard material event disclosure with no quantitative metrics or further context provided.
27-01-2026
RateGain Travel Technologies Ltd (BSE: 543417) has made a disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, received by BSE on January 27, 2026, pertaining to Plutus Wealth Management LLP and Persons Acting in Concert (PAC). This filing indicates a substantial acquisition or change in shareholding that crosses specified regulatory thresholds. No quantitative details such as share count, percentage stake, transaction value, or financial impact are disclosed.
27-01-2026
Premier Polyfilm Ltd (BSE: 514354) has made a disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, received by BSE on January 27, 2026, pertaining to Amar Nath Goenka. This regulation mandates intimation for acquisitions resulting in 5% or more shareholding or subsequent acquisitions by persons already holding 5% or more. No quantitative details such as share count, percentage stake, transaction value, or dates of acquisition were disclosed in the filing.
27-01-2026
BSE has received disclosures under Regulation 29(1) & 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Nectar Lifesciences Ltd (BSE: 532649) from Sanjiv Goyal & Others. This filing indicates a substantial acquisition of shares or intention to acquire shares crossing regulatory thresholds, but no specific details on shareholding changes, percentages, or transaction values are provided. No positive or negative financial metrics, deal sizes, or further impacts are disclosed in the filing.
27-01-2026
BSE received a disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, for Rama Petrochemicals Ltd (500358) from Rainbow Agri Industries Ltd & Others, indicating intention to acquire shares that may cross substantial shareholding thresholds. No details on deal structure, valuation, stake percentage, or transaction terms were provided in the filing. This is a regulatory compliance notice with no financial or strategic metrics disclosed.
27-01-2026
BSE received a disclosure under Regulation 10(6) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 from Nectar Lifesciences Ltd (532649) on January 27, 2026, pertaining to Sanjiv Goyal & Others. The filing confirms receipt of SAST disclosure but provides no details on transaction structure, shareholding changes, deal size, or financial impact. No quantitative metrics, positive or negative performance indicators, or further context are disclosed.
27-01-2026
Quality Power Electrical Equipments Ltd (544367) has provided an update under Regulation 30 (LODR) on its acquisition, intimating the nomination of Mr Ashish Bhardwaj (DIN: 11489538) as Nominee Director on the Board of Sukrut Electric Company Private Limited. No financial details, deal structure, valuation, or timelines are disclosed in the filing. This appears to be a post-acquisition governance step with no quantitative metrics provided.
27-01-2026
Yash Highvoltage Ltd announced under Regulation 30 (LODR) an update on its acquisition, nominating Mr. Darshan Ramesh Thakkar as a Nominee Director on the Board of Sukrut Electric Company Private Limited. No deal structure, valuation, financial terms, or strategic rationale details are disclosed in the filing. This indicates progress in the acquisition process through board representation.
27-01-2026
BSE received a disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011, from Vinod Dugar & PACs pertaining to RDB Real Estate Constructions Ltd (544346). No details on acquisition size, structure, shareholding changes, or transaction value were provided in the filing. This is an early-stage disclosure indicating potential intention to acquire shares crossing SAST thresholds.
27-01-2026
BSE received a disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 from Smita Kataria for Avi Products India Ltd (BSE: 523896), signaling intention to acquire shares that may trigger substantial acquisition thresholds. No quantitative details such as share count, stake percentage, deal value, or transaction structure are provided in the filing. This is an early-stage regulatory disclosure with no further facts on parties, rationale, or impact.
27-01-2026
Bai-Kakaji Polymers Ltd (BSE: 544670) announced under Regulation 30 (LODR) that its Board of Directors has approved the incorporation of a Wholly Owned Subsidiary named Mundada Polymers Private Limited, labeled as an Acquisition. No financial details, deal size, valuation, strategic rationale, or timelines were disclosed in the filing. This is a purely informational disclosure with no quantitative metrics or performance indicators provided.
27-01-2026
Maithan Alloys Ltd (BSE: 590078) announced under Regulation 30 (LODR) the incorporation of a new subsidiary of the Company on January 27, 2026. No details on the subsidiary's name, purpose, investment amount, or strategic rationale were provided. This is a routine corporate disclosure with no quantitative financial impact or performance metrics disclosed.
27-01-2026
Bikaji Foods International Ltd (BSE: 543653) announced an additional subscription in its wholly-owned subsidiary, Bikaji Foods Retail Limited, under Regulation 30 of SEBI (LODR). This is classified as an acquisition in the filing title, involving further equity investment by the parent into its subsidiary. No financial details, deal size, valuation, or strategic rationale were disclosed.
27-01-2026
Hazoor Multi Projects Limited (BSE: 532467) announced under Regulation 30 (LODR) the conversion of its existing investment in Optionally Convertible Debentures (OCD) in Square Port Shipyard Private Limited, its wholly owned subsidiary, classified as an acquisition. No quantitative details such as deal size, valuation, consideration type, or financial impact were disclosed in the filing. The event occurred on January 27, 2026, with no further strategic rationale or shareholder implications provided.
27-01-2026
GeeCee Ventures Limited announced an update under Regulation 30 (LODR) on its acquisition activities, specifically the payment of the first call of Adani Enterprises Limited. No deal structure details, financial metrics, valuation, or quantitative impacts were disclosed in the filing. The announcement was made on BSE on January 27, 2026, pertaining to the technology sector.
27-01-2026
Peninsula Land Ltd (503031) announced under Regulation 30 (LODR) an investment by its wholly owned subsidiary, Peninsula Holdings and Investments Private Limited (PHIPL), in M/s. Zenithvista Real Estate LLP. No deal size, valuation, financial terms, or strategic rationale were disclosed in the filing. The announcement is purely informational with no quantitative metrics provided.
Get daily alerts with 12 investment signals, 10 risk alerts, 10 opportunities and full AI analysis of all 34 filings
๐ฎ๐ณ More from India
View all โMarch 26, 2026
India Pre-Market Regulatory Roundup โ March 26, 2026
India Pre-Market Regulatory Roundup
March 26, 2026
India Quarterly Results BSE NSE Announcements โ March 26, 2026
India Quarterly Results BSE NSE Announcements
March 26, 2026
India Upcoming Corporate Actions BSE NSE โ March 26, 2026
India Upcoming Corporate Actions BSE NSE
March 25, 2026
India Pre-Market Regulatory Roundup โ March 25, 2026
India Pre-Market Regulatory Roundup